By Kevin Hrusovsky, Executive Chairman and CEO, Quanterix
We are privileged to live in a society that values science, technology, engineering and mathematics. Better known as STEM, these programs play a critical role in the advancement of our society, and are shaping the future of medicine and other disciplines.
By Kevin Hrusovsky, EXECUTIVE CHAIRMAN AND CEO, QUANTERIX
As a company that believes we have the power to improve player safety, we also know that change cannot happen unless we have unified support from the entire community, including researchers, scientists, doctors, patients, patient advocates, investors, and institutions like the NFL.
By Dr. Mark Roskey and Dr. David Duffy
We were honored to be able to speak about the promise of immuno-oncology (IO) therapeutics at this year’s Molecular Med Tri-Con conference and the 12th Annual Biomarkers Congress.
BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX
2016 has been a banner year for the healthcare and life sciences industries. This year we saw the launch of critical initiatives like the Vice President Biden’s Cancer Moonshot, aimed at improving our ability to prevent cancer and detect it an early stage.